From Chemical Graphs in Computer-Aided Drug Design to General Markov-Galvez Indices of Drug-Target, Proteome, Drug-Parasitic Disease, Technological, and Social-Legal Networks
Journal:
Current Computer-Aided Drug Design
Volume:
7
Page:
315-337
Author(s):
Pablo Riera-Fernandez, Cristian R. Munteanu, Julian Dorado, Raquel Martin-Romalde, Aliuska Duardo-Sanchez and Humberto Gonzalez-Diaz
Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5507-5518
Author(s):
K. C. Sheng, M. D. Wright and V. Apostolopoulos
Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5528-5544
Author(s):
D. A. Sabbah, M. G. Brattain and H. Zhong
Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5598-5623
Author(s):
D. K. Nevin, D. G. Lloyd and D. Fayne
Heat Shock Proteins: A Potential Anticancer Target
Journal:
Current Drug Targets
Volume:
12
Page:
2001-2008
Author(s):
Kamalesh K. Sankhala, Monica M. Mita, Alain C. Mita and Chris H. Takimoto
Vascular Disrupting Agents (VDA) in Oncology: Advancing Towards New Therapeutic Paradigms in the Clinic
Journal:
Current Drug Targets
Volume:
12
Page:
2009-2015
Author(s):
Matthew A. Spear, Patricia LoRusso, Alain Mita and Monica Mita
Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers
Journal:
Current Drug Targets
Volume:
12
Page:
2016-2033
Author(s):
Eric K. Rowinsky, Jonathan D. Schwartz, Naseem Zojwalla, Hagop Youssoufian, Floyd Fox, Philippe Pultar, Ruslan Novosyadlyy, Jan Cosaert and Dale L. Ludwig
Targeting Trail Towards the Clinic
Journal:
Current Drug Targets
Volume:
12
Page:
2079-2090
Author(s):
Devalingam Mahalingam, Corina N.A.M. Oldenhuis, Eva Szegezdi, Francis J. Giles, Elisabeth G.E. de Vries, Steven de Jong and Steffan T. Nawrocki
The Hedgehog Knows Many Tricks
Journal:
Current Drug Targets
Volume:
12
Page:
2091-2095
Author(s):
Glen J. Weiss, Alain C. Mita and Daniel D. Von Hoff
TGF-Beta Type I Receptor (Alk5) Kinase Inhibitors in Oncology
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
2190-2202
Author(s):
Leona E. Ling and Wen-Cherng Lee